Long-acting HIV prevention meds: 10 Breakthrough Technologies 2025
WHO Gilead Sciences, GSK, ViiV Healthcare WHEN 1 to 3 years In June 2024, results from a trial of a new medicine to prevent HIV were announced—and they were jaw-dropping. Lenacapavir, a treatment injected once every six months, protected over 5,000 girls and women in Uganda and South Africa from getting HIV. And it was…